LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Progress in Molecular Biology and Translational Science, Volume 160 provides the most topical, informative and exciting monographs available on a wide variety of research topics re… Read more
LIMITED OFFER
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Progress in Molecular Biology and Translational Science, Volume 160 provides the most topical, informative and exciting monographs available on a wide variety of research topics related to prions, viruses, bacteria and eukaryotes. The series gives in-depth knowledge on the important molecular biological aspects of organismal physiology and function, along with insights on how this knowledge can be applied to understand and ameliorate human disease. This updated release covers Clinical Drugs in the Environment, Group I Intron Trans-Splicing, Adult Stem Cells on Regenerative Therapy, CRISPR in Animals and Animal Models, The Role of 3’–5’Exoribonucleases in RNA Degradation, and more.
Scientists working actively in a field, including those at levels ranging from graduate student to senior investigator. Volumes also are appropriate for new investigators to a field who wish to familiarize themselves with the latest work
Preface
David B. Teplow
1. Adult Stem Cells for Regenerative Therapy
Narasimman Gurusamy, Abdulrhman Alsayari, Sheeja Rajasingh and
Johnson Rajasingh
2. Hair Follicle-Associated Pluripotent (HAP) Stem Cells
Robert M. Hoffman and Yasuyuki Amoh
3. Fluorescent Proteins as Sensors for Cellular Behavior in Mice
Robert M. Hoffman
4. Arrestins: Introducing Signaling Bias Into Multifunctional Proteins
Vsevolod V. Gurevich, Qiuyan Chen and Eugenia V. Gurevich
5. Analysis of Biased Agonism
Frederick J. Ehlert
6. Effects of Estrogens on Central Nervous System Neurotransmission: Implications for Sex Differences in Mental Disorders
Kristen N. Krolick, Qi Zhu and Haifei Shi
DT
David B. Teplow, Ph.D., is a Professor of Neurology, Emeritus, at UCLA and an internationally recognized leader in efforts to understand and treat Alzheimer's disease. Dr. Teplow's group has used a multi-disciplinary approach to determine how neurotoxic peptides, such as the amyloid β-protein (Alzheimer's disease) and α-synuclein (Parkinson’s disease), form neurotoxic structures that kill neurons and to develop the means to block these processes. Dr. Teplow received undergraduate training at UC Berkeley; a Ph.D. from the University of Washington; and was a postdoctoral scholar at Caltech. Before coming to UCLA, Dr. Teplow was a faculty member in the Department of Neurology, Harvard Medical School. Dr. Teplow has published >250 peer-reviewed articles, books and book chapters, and commentaries, in addition to serving on numerous national and international scientific advisory boards. Dr. Teplow was a founding editor of the Journal of Molecular Neuroscience and Current Chemical Biology, He is Co-Editor-in-Chief of the Elsevier serial Progress in Molecular Biology and Translational Science and is Associate Editor-in-Chief of the American Journal of Neurodegenerative Disease.